Derrick advises leading US and international public companies, as well as their boards of directors, on their transformative M&A transactions and other transactional matters. He has extensive experience advising publicly traded and privately held companies on domestic and cross-border transactions, including acquisitions and divestitures (including negotiated transactions, contested takeovers and topping bids), joint ventures, tender and exchange offers, minority investments, spinoffs and carveouts.

Derrick regularly counsels clients in a variety of industries, in a variety of industries, including healthcare and life sciences, technology, media & telecommunications and financial services, among others.

In addition, Derrick also regularly represents investment banks as financial advisors on M&A transactions.

In 2023, Derrick was recognized by Bloomberg Law in its ‘They’ve Got Next: 40 Under 40’, a Rising Star in Mergers & Acquisitions by Law360 and a Rising Star In Mergers & Acquisitions by New York Law Journal.

Expertise

Industries

Experience

Representative matters

Public Company Mergers & Acquisitions:
  • CVS Health Corp. on its $10.6 billion acquisition of Oak Street Health.
  • Boston Scientific on its $3.7 billion acquisition of Axonics and its $615 million acquisition of Apollo Endosurgery.
  • JetBlue Airways Corp. on its $3.8 billion acquisition of Spirit Airlines.
  • GSK on its $5.1 billion acquisition of TESARO, Inc.
  • Unibail-Rodamco on its $25 billion acquisition of Westfield Corporation.
  • Dassault Systèmes S.E. on its $400 million acquisition of Exa Corporation.
  • Textron Inc. on its $247 million acquisition of Arctic Cat Inc.
  • Wausau Paper Corp. on its $514 million sale to Svenska Cellulosa Aktiebolaget.
  • Sun Pharmaceuticals Industries in its $48 million acquisition of InSite Vision Inc.
  • Pall Corporation on its $13.8 billion sale to Danaher Corporation.
  • Liberty Global plc on its $25 billion acquisition of Virgin Media.
Private Strategic Mergers & Acquisitions:
  • Boston Scientific on its $800 million divestiture of BTG Specialty Pharmaceuticals to portfolio companies of Charterhouse Capital Partners.
  • Altice USA, Inc. on its acquisition of Audience Partners, LLC, and its divestiture of a majority stake of Newsday to Patrick Dolan.
  • Bunge Limited on its divestiture of 35 U.S. interior elevators to Zen-Noh Grain Corporation.
  • S&P Global, Inc. on its divestiture of J.D. Power & Associates to XIO Group and its divestiture of the McGraw Hill Construction division to Symphony Technology Group.
  • Banco Bradesco S.A. on its $500 million acquisition of BAC Florida Bank.
  • General Electric Company on its sale of its energy finance business to Starwood Property Trust, Inc.
  • The National Hockey League’s Arizona Coyotes on the sale of 51% of the franchise to Andrew Barroway.
  • Pall Corporation on its acquisition of the life sciences business of ATMI, Inc.
  • Ardagh Group S.A. on its sale of Anchor Glass Container Corporation to KPS Capital Partners, LP.
Joint Ventures:
  • Société Générale on the formation of its joint venture with AllianceBernstein.
  • Altice USA, Inc. on its joint venture with, and its sale of a 49.99 percent of its LightPath fiber enterprise business to, Morgan Stanley Infrastructure Partners.
  • Bunge Limited on its joint venture with, and its acquisition of a 70% ownership interest in IOI Loders Croklaan from, IOI Corporation Berhad.
  • Anglo American on its sale of a minority shareholding in Anglo American Sur (Chile) to, and the negotiation of related partnership arrangements, with Mitsubishi Corporation.
Private Equity:
  • Tarsadia Capital on the sale of 100% of its interests in Igneo Holdings to Korea Zinc.
  • Amherst Pierpont Securities on its $600 million sale to Banco Santandar.
  • Ness Digital Engineering, a portfolio company of The Rohatyn Group (TRG), in its acquisition of Linium, LLC.
  • Pierpont Securities LLC in its merger with Amherst Securities Group LP.
Other Transactional Matters:
  • CVS Health Ventures on its $100 Series D investment in Carbon Health.
  • Altice USA, Inc. on its initial public offering of shares and its spin-off from Altice Europe N.V.
  • IG4 Capital on its cash tender offer for 12.29 percent of the common shares of Aenza S.A.A.
  • Liberty Global on its “modified Dutch Auction” tender offer to purchase up to $2.5 billion of its ordinary shares. 
  • LyondellBasell on its “modified Dutch Auction” tender offer to purchase up to 37,000,000 of its ordinary shares.

Speaking Engagements

  • Corporate Board Member’s 19th Annual Boardroom Summit – Panelist on “M&A Rules of Engagement for the Board”
  • Corporate Board Member’s 18th Annual Boardroom Summit – Panelist on “Would Your M&A Transaction Withstand a Shareholder Challenge?”
  • Corporate Board Member’s 17th Annual Boardroom Summit – Panelist on “The Board’s Role in Improving M&A Deal Outcomes”

Leadership Positions And Professional Affiliations

  • Fellow, Leadership Council on Legal Diversity (2017 Class)

Awards

  • Recommended Lawyer, M&A/Corporate and Commercial: M&A: Large Deals ($1BN+), Legal 500 USA, 2023 
  • Rising Star in Mergers & Acquisitions, Law360, 2023
  • Rising Star in Mergers & Acquisitions, New York Law Journal, 2023
  • ‘They’ve Got Next: 40 Under 40’ in Mergers & Acquisitions, Bloomberg Law, 2023
  • Rising Star, The Dealmaker Quarterly, 2019

Qualifications

Admissions

New York, 2010

Academic

B.A., Economics, Washington & Lee University, 2006
J.D., American University Washington College of Law, 2009
Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.